Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 110–110 | Cite as

Docetaxel/nintedanib

Various toxicities: 6 case reports
Case report
  • 13 Downloads

Reference

  1. Hong S-H, et al. Impact of epidermal growth factor receptor mutation on clinical outcomes of nintedanib plus docetaxel in patients with previously treated non-small cell lung cancer from the Korean named patient program. Oncology 96: 51-58, No. 1, 2019. Available from: URL: http://doi.org/10.1159/000492472 - South Korea

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations